Kaili Xing
Overview
Explore the profile of Kaili Xing including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
71
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ma L, Zhang C, Wen Y, Xing K, Li S, Geng Z, et al.
Int J Surg
. 2024 Jul;
111(1):872-883.
PMID: 39051653
Background: Patients with microvascular invasion (MVI)-positive hepatocellular carcinoma (HCC) have shown promising results with adjuvant hepatic arterial infusion chemotherapy (HAIC) with FOLFOX after curative resection. The authors aim to develop...
2.
Xiong W, He W, Wang T, He S, Xu F, Wang Z, et al.
Adv Sci (Weinh)
. 2022 Jan;
9(7):e2103029.
PMID: 35064757
Smad4, a key mediator of the transforming growth factor-β signaling, is mutated or deleted in 20% of pancreatic ductal adenocarcinoma (PDAC) cancers and significantly affects cancer development. However, the effect...
3.
Lu L, Xing K, Wei W, Ling Y, Li P, Li S, et al.
Int J Cancer
. 2021 Apr;
PMID: 33890283
Immune checkpoint blockade has demonstrated remarkable efficacy in hepatocellular carcinoma (HCC) but is also commonly accompanied by immune-related adverse events (irAEs). However, the association between irAEs and antitumor efficacy in...
4.
Song Y, Sun X, Duan F, He C, Wu J, Huang X, et al.
Front Oncol
. 2020 Oct;
10:1482.
PMID: 33042794
Synaptophysin-like 1 (SYPL1) is a neuroendocrine-related protein. The role of SYPL1 in pancreatic ductal adenocarcinoma (PDAC) and the underlying molecular mechanism remain unclarified. Here, after analyzing five datasets (GSE15471, GSE16515,...
5.
Huang X, He C, Lin G, Lu L, Xing K, Hua X, et al.
Biochem Biophys Res Commun
. 2020 Feb;
524(4):1064-1071.
PMID: 32070494
Objective: Tumor associated macrophages (TAMs) promoted pancreatic ductal adenocarcinoma (PDAC) initiation and progression. In this study we aimed to evaluate CD10 expression by monocytes/macrophages and its clinical significance in PDAC....
6.
He C, Zhang Y, Song Y, Wang J, Xing K, Lin X, et al.
J Cancer
. 2018 Sep;
9(17):3117-3128.
PMID: 30210635
There are few diagnostic tools that can be used to determine which patient with intrahepatic cholangiocarcinoma (ICC) can benefit from surgery actually, highlighting that the need for new preoperative stratification...